Wilbanks Smith & Thomas Asset Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $260K | Hold |
2,438
| – | – | 0.01% | 476 |
|
|
2023
Q4 | $242K | Hold |
2,438
| – | – | 0.01% | 474 |
|
|
2023
Q3 | $252K | Sell |
2,438
-1,212
| -33% | -$125K | 0.01% | 436 |
|
|
2023
Q2 | $443K | Buy |
3,650
+500
| +16% | +$60.8K | 0.01% | 340 |
|
|
2023
Q1 | $484K | Hold |
3,150
| – | – | 0.02% | 308 |
|
|
2022
Q4 | $566K | Hold |
3,150
| – | – | 0.02% | 289 |
|
|
2022
Q3 | $372K | Sell |
3,150
-400
| -11% | -$47.2K | 0.02% | 327 |
|
|
2022
Q2 | $507K | Buy |
3,550
+400
| +13% | +$57.1K | 0.02% | 294 |
|
|
2022
Q1 | $462K | Sell |
3,150
-127
| -4% | -$18.6K | 0.02% | 319 |
|
|
2021
Q4 | $832K | Buy |
3,277
+1,089
| +50% | +$276K | 0.03% | 259 |
|
|
2021
Q3 | $842K | Sell |
2,188
-950
| -30% | -$366K | 0.03% | 239 |
|
|
2021
Q2 | $737K | Hold |
3,138
| – | – | 0.03% | 260 |
|
|
2021
Q1 | $411K | Sell |
3,138
-150
| -5% | -$19.6K | 0.02% | 318 |
|
|
2020
Q4 | $343K | Buy |
3,288
+4
| +0.1% | +$417 | 0.02% | 313 |
|
|
2020
Q3 | $232K | Hold |
3,284
| – | – | 0.01% | 353 |
|
|
2020
Q2 | $211K | Buy |
+3,284
| New | +$211K | 0.01% | 367 |
|